Related articles:

Tesaro Inc.: TESARO Announces Fourth-Quarter 2016 Operating Results
February 28, 2017
February 28, 2017

Tesaro Inc.: TESARO Announces Participation at Two Investor Conferences
February 21, 2017
February 21, 2017

Tesaro Inc.: Tesaro Announces Participation at Two Investor Conferences
February 02, 2017
February 2, 2017

Tesaro Inc.: Tesaro to Announce Third-Quarter 2016 Financial Results on November 3, 2016
October 20, 2016
October 20, 2016

Tesaro Inc.: TESARO and Zai Lab Announce Collaboration, Development and License Agreement
September 29, 2016
September 29, 2016

Tesaro Inc.: Read this press release »
August 04, 2016
August 4, 2016

Tesaro Inc.: Tesaro Announces Second-Quarter 2016 Operating Results
August 04, 2016

Tesaro Inc.: ENGOT and TESARO Partnership Generates Positive Data From ENGOT-OV16/NOVA Phase 3 Trial
July 08, 2016
July 8, 2016

Tesaro Inc.: TESARO's Niraparib Significantly Improved Progression-Free Survival for Patients With Ovarian Cancer in Both Cohorts of the Phase 3 NOVA Trial
June 29, 2016
June 29, 2016

Tesaro Inc.: TESARO Provides Pipeline Update at ASCO Investor Briefing
June 04, 2016
June 4, 2016

Tesaro Inc.: TESARO to Announce First Quarter 2016 Financial Results on May 5, 2016
April 21, 2016
April 21, 2016

Tesaro Inc.: TESARO Announces Global Prostate Cancer Collaboration and Licensing Agreement With Janssen
April 06, 2016
April 6, 2016

Tesaro Inc.: TESARO Announces Appointment of Dr. Kavita Patel to Board of Directors
April 04, 2016
April 4, 2016

Tesaro Inc.: Read this press release »
February 25, 2016
February 25, 2016

Tesaro Inc.: TESARO Announces Fourth-Quarter 2015 Operating Results
February 25, 2016

Tesaro Inc.: Tesaro to Announce Fourth Quarter 2015 Financial Results on February 25, 2016
February 11, 2016
February 11, 2016

Tesaro Inc.: TESARO Added to the NASDAQ Biotechnology Index
December 14, 2015
December 14, 2015

Tesaro Inc.: TESARO Announces Third-Quarter 2015 Operating Results
October 29, 2015
October 29, 2015

Tesaro Inc.: TESARO to Announce Third-Quarter Financial Results on October 29, 2015
October 15, 2015
October 15, 2015

Tesaro Inc.: TESARO Appoints Martin Huber, M.D., as Senior Vice President and Chief Medical Officer
September 21, 2015
September 21, 2015

Tesaro Inc.: TESARO Announces Second-Quarter 2015 Operating Results
August 06, 2015
August 6, 2015

Tesaro Inc.: Tesaro and Jiangsu Hengrui Medicine Announce Rolapitant License Agreement for China
July 30, 2015
July 30, 2015

Tesaro Inc.: TESARO to Announce Second-Quarter Financial Results on August 6, 2015
July 23, 2015
July 23, 2015

Tesaro Inc.: TESARO Appoints Grant C. Bogle As Senior Vice President and Chief Commercial Officer
July 13, 2015
July 13, 2015

Tesaro Inc.: TESARO Appoints Jeffrey H. Hanke, Ph.D., as Executive Vice President, Research & Development, and Chief Scientific Officer
June 29, 2015
June 29, 2015

Tesaro Inc.: TESARO and Merck to Collaborate on a Combination Study of Niraparib and KEYTRUDA(R) (Pembrolizumab)
May 30, 2015
May 30, 2015

Tesaro Inc.: TESARO Announces Election of Garry A. Nicholson to Board of Directors and Results of Annual Stockholder Meeting
May 14, 2015
May 14, 2015

Tesaro Inc.: TESARO Announces First-Quarter 2015 Operating Results
April 30, 2015
April 30, 2015

Tesaro Inc.: TESARO to Announce First-Quarter Financial Results on April 30, 2015
April 16, 2015
April 16, 2015

Tesaro Inc.: TESARO Announces Nomination of Garry A. Nicholson for Election to Board of Directors
April 09, 2015
April 9, 2015

Tesaro Inc.: TESARO Appoints Joseph Farmer, as Senior Vice President, General Counsel and Secretary
March 31, 2015
March 31, 2015

Tesaro Inc.: TESARO to Announce Fourth-Quarter 2014 Financial Results on February 19, 2015
February 05, 2015
February 5, 2015

Tesaro Inc.: TESARO and AnaptysBio Expand Immuno-Oncology Collaboration to Include Novel Bispecific Antibody Candidate
December 02, 2014
December 2, 2014

Tesaro Inc.: TESARO and Myriad Announce Companion Diagnostics Collaboration
November 20, 2014
November 20, 2014

Tesaro Inc.: TESARO Announces Third-Quarter 2014 Operating Results
November 05, 2014
November 5, 2014

Tesaro Inc.: Tesaro to Announce Third-Quarter 2014 Financial Results on November 5, 2014
October 22, 2014
October 22, 2014

Tesaro Inc.: TESARO Announces Closing of $201.25 Million Public Offering of 3.00% Convertible Senior Notes Due 2021, Including Full Exercise of the Underwriters' Option to Purchase Additional Notes
September 29, 2014
September 29, 2014

Tesaro Inc.: TESARO Announces Pricing of $175 Million of 3.00% Convertible Senior Notes Due 2021
September 23, 2014
September 23, 2014

Tesaro Inc.: TESARO Announces Offering of $165 Million of Convertible Senior Notes Due 2021
September 22, 2014
September 22, 2014

Tesaro Inc.: TESARO Announces Second-Quarter 2014 Operating Results
July 24, 2014
July 24, 2014

Tesaro Inc.: TESARO to Announce Second-Quarter 2014 Financial Results on July 24, 2014
July 10, 2014
July 10, 2014

Tesaro Inc.: TESARO Announces Election of Earl M. (Duke) Collier, Jr. to Board of Directors and Results of Annual Stockholder Meeting
May 16, 2014
May 16, 2014

Tesaro Inc.: TESARO Announces First-Quarter 2014 Operating Results
April 30, 2014
April 30, 2014

Tesaro Inc.: TESARO to Announce First Quarter 2014 Financial Results on April 30, 2014
April 16, 2014
April 16, 2014

Tesaro Inc.: TESARO and AnaptysBio Announce Collaboration and Exclusive Worldwide License Agreement for Multiple Immuno-Oncology Programs
March 13, 2014
March 13, 2014

Tesaro Inc.: TESARO Announces Fourth-Quarter and Full-Year 2013 Operating Results
February 19, 2014
February 19, 2014

Tesaro Inc.: TESARO to Announce Fourth Quarter 2013 Financial Results on February 19, 2014
February 07, 2014
February 7, 2014

Tesaro Inc.: TESARO Announces Pricing of Public Offering of Common Stock
January 29, 2014
January 29, 2014

Tesaro Inc.: TESARO Announces Proposed Public Offering of Common Stock
January 28, 2014
January 28, 2014

Pin It on Pinterest

Share This